Document is current
Any future updates will be listed below
-
Authors
Liu, Bei http://orcid.org/0000-0003-2155-2974
Shi, Honglue http://orcid.org/0000-0003-3847-1652
Rangadurai, Atul
Nussbaumer, Felix
Chu, Chia-Chieh
Erharter, Kevin Andreas
Case, David A.
Kreutz, Christoph http://orcid.org/0000-0002-7018-9326
Al-Hashimi, Hashim M. http://orcid.org/0000-0003-0681-1747
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI150470)
Austrian Science Fund (P30370)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R01GM132899, R01GM089846)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 6 January 2021
Accepted: 21 July 2021
First Online: 31 August 2021
Competing interests
: H.M.A. is an advisor to and holds an ownership interest in Nymirum, an RNA-based drug discovery company. C.K. is an advisor to and holds an ownership interest in INNotope, a company providing RNA stable isotope labeling products. The remaining authors declare no competing interests.
